Day One Biopharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-04-22
Previous score
7.27
Change
0
The current valuation score of Day One Biopharmaceuticals Inc is 7.27, ranking 137 out of 390 in the Biotechnology & Medical Research industry. Its current P/E ratio is -20.70, which is -79.63% below the recent high of -4.22 and 0.00% above the recent low of -20.70.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.